![Kim-Hien Dao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kim-Hien Dao
Chief Tech/Sci/R&D Officer at
ELECTRA THERAPEUTICS, INC.
Net worth: - $ as of 2026-08-30
Profile
Kim-Hien Dao is Chief Medical Officer at Electra Therapeutics, Inc. since 2024.
Formerly, Dr. Dao was Executive Medical Director-Clinical Development at Astex Pharmaceuticals, Inc. from 2019 to 2023.
Dr. Dao earned a doctorate from Michigan State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-17 | 0 ( -.--% ) | - $ | 2026-08-30 |
Kim-Hien Dao active positions
| Companies | Position | Start |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-03-31 |
Former positions of Kim-Hien Dao
| Companies | Position | End |
|---|---|---|
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Chief Tech/Sci/R&D Officer | 2023-02-28 |
Training of Kim-Hien Dao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
- Stock Market
- Insiders
- Kim-Hien Dao
